| The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease | 2010/09/28 | English | 214 |
| The RAAS in the pathogenesis and treatment of diabetic nephropathy | 2010/05/04 | English | 214 |
| Sickle cell disease: renal manifestations and mechanisms | 2015/02/10 | English | 213 |
| Redefining lupus nephritis: clinical implications of pathophysiologic subtypes | 2017/07/03 | English | 212 |
| Anaemia in kidney disease: harnessing hypoxia responses for therapy | 2015/06/09 | English | 212 |
| Fluid management for the prevention and attenuation of acute kidney injury | 2013/11/12 | English | 208 |
| HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | 2015/12/14 | English | 206 |
| Genetic, environmental, and epigenetic factors involved in CAKUT | 2015/08/18 | English | 206 |
| Causes and pathogenesis of focal segmental glomerulosclerosis | 2014/12/02 | English | 205 |
| Fibroblast activation and myofibroblast generation in obstructive nephropathy | 2009/06/01 | English | 205 |
| The immunology of renal cell carcinoma | 2020/07/30 | English | 205 |
| Extracellular vesicles in renal disease | 2017/07/24 | English | 204 |
| Cellular senescence in renal ageing and disease | 2016/12/28 | English | 203 |
| Cellular senescence: the good, the bad and the unknown | 2022/08/03 | English | 203 |
| Mitochondrial quality control in kidney injury and repair | 2020/11/24 | English | 201 |
| Birth weight, malnutrition and kidney-associated outcomes—a global concern | 2015/01/20 | English | 201 |
| Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease | 2017/02/20 | English | 198 |
| Understanding and preventing contrast-induced acute kidney injury | 2017/01/31 | English | 198 |
| Nephrology in China | 2013/07/23 | English | 197 |
| An update on primary hyperoxaluria | 2012/06/12 | English | 197 |
| C3 glomerulopathy — understanding a rare complement-driven renal disease | 2019/01/28 | English | 196 |
| WNT–β-catenin signalling — a versatile player in kidney injury and repair | 2020/09/28 | English | 193 |
| Mechanisms of hypoxia signalling: new implications for nephrology | 2019/09/05 | English | 192 |
| The role of inflammasomes in kidney disease | 2019/06/04 | English | 192 |
| Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | 2020/04/03 | English | 191 |
| Diverse origins of the myofibroblast—implications for kidney fibrosis | 2015/01/13 | English | 190 |
| Uromodulin: from physiology to rare and complex kidney disorders | 2017/08/07 | English | 188 |
| HNF1B-associated renal and extra-renal disease—an expanding clinical spectrum | 2014/12/23 | English | 187 |
| Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD | 2017/05/15 | English | 186 |
| Reducing the costs of chronic kidney disease while delivering quality health care: a call to action | 2017/05/30 | English | 186 |